I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
Polatuzumab vedotin, rituximab, and bendamustine combinatio..:
Dal, Mehmet Sinan
;
Ulu, Bahar Uncu
;
Uzay, Ant
...
Annals of Hematology. , 2023
Link:
https://hdl.handle.net/20.500.12511/10517
RT Journal T1
Polatuzumab vedotin, rituximab, and bendamustine combination in relapsed or refractory diffuse large B-cell lymphoma: A real-world data from Turkey
UL https://suche.suub.uni-bremen.de/peid=base-ftistanbulmedipo:oai:acikerisim.medipol.edu.tr:20.500.12511_10517&Exemplar=1&LAN=DE A1 Dal, Mehmet Sinan A1 Ulu, Bahar Uncu A1 Uzay, Ant A1 Akay, Olga Meltem A1 Beşışık, Sevgi A1 Yenerel, Mustafa Nuri A1 Çelik, Serhat A1 Kaynar, Leylagül A1 Yücel, Orhan Kemal A1 Deveci, Burak A1 Sönmez, Mehmet A1 Mehtap, Özgür A1 Beköz, Hüseyin Saffet A1 Sunu, Cenk A1 Salim, Ozan A1 Ulaş, Turgay A1 Kartı, Sami A1 Altuntaş, Fevzi A1 Ferhanoğlu, Burhan A1 Tuğlular, Tülin Fırat PB Springer YR 2023 K1 Bendamustine K1 Diffuse Large B-cell Lymphoma K1 Polatuzumab Vedotin K1 Refractory K1 Relapsed K1 Rituximab JF Annals of Hematology LK http://dx.doi.org/https://hdl.handle.net/20.500.12511/10517 DO https://hdl.handle.net/20.500.12511/10517 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)